Bausch Health Companies Inc.
BHC.TOTSXHealthcare● Active
$7.49
+$0.18(+2.46%)
Market Cap$2.8B
P/E Ratio—
52W High$11.97
52W Low$6.29
Bausch Health Companies Inc. (BHC.TO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BHC.TO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $10.45B | $9.63B | $8.76B | $8.12B | $8.43B |
| Cost of Revenue | $4.08B | $2.78B | $2.56B | $2.36B | $2.39B |
| Gross Profit | $6.36B | $6.84B | $6.20B | $5.76B | $6.04B |
| Gross Margin %(computed) | 60.90% | 71.10% | 70.78% | 70.90% | 71.61% |
| Operating Expenses | |||||
| R&D Expenses | $0.64B | $0.62B | $0.60B | $0.53B | $0.47B |
| G&A Expenses | $0.00B | $2.50B | $2.27B | $2.11B | $2.11B |
| Total Operating Expenses | $4.14B | $5.30B | $5.24B | $4.40B | $4.84B |
| Operating Income | $2.22B | $1.55B | $0.96B | $1.37B | $1.21B |
| Operating Margin %(computed) | 21.28% | 16.06% | 11.00% | 16.86% | 14.35% |
| Interest Income | $0.05B | $0.03B | $0.03B | $0.01B | $0.01B |
| Interest Expense | $1.64B | $1.39B | $1.33B | $1.46B | $1.43B |
| Income Before Tax | $0.37B | $0.17B | ($0.39B) | ($0.13B) | ($1.02B) |
| Income Tax Expense | $0.25B | $0.24B | $0.22B | $0.08B | ($0.09B) |
| Net Income | $0.16B | ($0.05B) | ($0.59B) | ($0.21B) | ($0.94B) |
| Net Margin %(computed) | 1.53% | -0.48% | -6.76% | -2.61% | -11.11% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.43 | $-0.12 | $-1.62 | $-0.59 | $-2.61 |
| Wtd Avg Shares | 0.37B | 0.37B | 0.36B | 0.36B | 0.36B |
| EBITDA | $3.45B | $2.82B | $2.20B | $2.88B | $3.26B |
| EBITDA Margin %(computed) | 33.05% | 29.32% | 25.15% | 35.43% | 38.65% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Bausch Health Companies Inc. data
About Bausch Health Companies Inc. (BHC.TO) Income Statement
Bausch Health Companies Inc. (BHC.TO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BHC.TO reported revenue of $10.45B, gross profit of $6.36B (gross margin 60.90%), and net income of $0.16B — a net profit margin of 1.53%.
Frequently asked questions
BHC.TO · 4 questionsBausch Health Companies Inc. (BHC.TO) reported revenue of $10.45B for 2025, up 8.5% year-over-year.
BHC.TO revenueBHC.TO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08